Molecular radiotheragnostics in prostate cancer
Yong Du and Sabina Dizdarevic
DOI: https://doi.org/10.7861/clinmedicine.17-5-458
Clin Med October 2017 Yong Du
ARoyal Marsden NHS Foundation Trust, London, UK
Roles: consultant in nuclear medicine and PET-CT
Sabina Dizdarevic
BBrighton and Sussex University Hospitals NHS Trust and honorary reader and BSMS PET-CT lead, Brighton and Sussex Medical School, Brighton, UK
Roles: principle lead consultant in imaging and nuclear medicine
Article Information
vol. 17 no. 5 458-461
PubMed:
Published By:
Print ISSN:
Online ISSN:
History:
- Published online October 3, 2017.
Copyright & Usage:
© Royal College of Physicians 2017. All rights reserved.
Author Information
- Yong Du, consultant in nuclear medicine and PET-CTA⇑ and
- Sabina Dizdarevic, principle lead consultant in imaging and nuclear medicineB
- ARoyal Marsden NHS Foundation Trust, London, UK
- BBrighton and Sussex University Hospitals NHS Trust and honorary reader and BSMS PET-CT lead, Brighton and Sussex Medical School, Brighton, UK
- Address for correspondence: Dr Yong Du, Department of Nuclear Medicine, The Royal Marsden NHS Foundation Trust, Downs Road, Sutton SM2 5PT, UK. Email: yong.du{at}rmh.nhs.uk
Article usage
Article Tools
Molecular radiotheragnostics in prostate cancer
Yong Du, Sabina Dizdarevic
Clinical Medicine Oct 2017, 17 (5) 458-461; DOI: 10.7861/clinmedicine.17-5-458
Citation Manager Formats
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.